Biotricity is trading 14.58% up at $0.06, with no clear company-specific catalyst identified for its October 7, 2026 move. - Its news-release archive shows no announcement dated October 7, and Schwab’s headlines list no news for the stock that day. - The S&P 500, Nasdaq and Dow are all lower, so the broader market context does not explain the gain; intraday volume details were not provided.